NCT07107828Completed
Effect of Rehabilitation on the Respiratory Signal in Patients With COPD and Exercise-Induced Desaturation
Effect of Rehabilitation on the Respiratory Signal in Patients With Chronic Obstrucitve Pulmonary Disease (COPD) and Exercise-Induced Desaturation
Source: ClinicalTrials.gov · Last updated 11 Sept 2026
Brief summary (registry, in English)
The aim is to study the effect of SSOT during a 3-week in-patient pulmonary rehabilitation programme. Further aim is to analyse exercise endurance, distinguishing between those exercising whilst breathing air at 760m "normoxia", breathing air at 1600m "hypoxia", or breathing SSOT at 760m "hyperoxia" conditions, during in-patient pulmonary rehabilitation. The objective of the main study is to provide long-awaited data concerning the use of SSOT during training. At present it is unclear whether patients with chronic lung diseases who reveal an SpO2 \> 88% at rest, but desaturate during exercise, and, thus, may not qualify for long-term oxygen undergoing PR benefit from supplemental oxygen. This sub-study will involve the subjects wearing the Respeck device and will focus on the effect of exercise on the respiratory signal measured by the Respeck.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 52 (actual)
- First submitted
- 16 Jul 2025
- Start date
- 23 Jul 2025
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Eastern Switzerland University of Applied Sciences
- Diseases
- COPD
- NCT number
- NCT07107828
What you commit to
- Study type: Interventional
- Participants enrolled: 52
- From 23 Jul 2025 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- long-term oxygen therapy
- unstable condition requiring adaptation of pharmacologic and other treatment modalities or requirement of intensive care or relevant severe concomitant disease
Other illness
- inability to follow the procedures of the study, e.g. due to language problems psychological disorders, neurological or orthopedic problems with walking disability or inability to ride a bicycle
Other
- Severe daytime resting hypoxemia (SpO2 \< 88%)
- women who are pregnant or breast feeding
- enrolment in another clinical trial with active treatment.
Who the study is looking for
- aged ≥ 18 years
- stable condition \> 3 weeks (e.g. no exacerbations)
- resting SpO2 ≥ 88% and exercise induced hypoxemia defined by a fall in SpO2 by ≥ 4% and/or below 90% during a 6-minute walk test (6MWT)
- informed consent as documented by signature.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National center for cardiology and internal medicine Coordinator of this site? Confirm its status | Bishkek | Kyrgyzstan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.